UCH-L1遺伝子は,アルファ-シヌクレインの分解とパーキンソン病の感受性に影響を与える2つの相反する酵素活動をコードする
Yichin Liu1, Lara Fallon, Hilal A Lashuel
1Center for Neurologic Diseases, Brigham and Women's Hospital, Department of Neurology, Harvard Medical School, Cambridge, MA 02139, USA.
Cell
|November 1, 2002
まとめ
Ubiquitin C-terminal hydrolase-L1 (UCH-L1) は,単にヒドロラーゼ活性ではなく,新たに発見されたリガゼ活性を持っています. この二重機能は,神経の健康とパーキンソン病 (PD) のリスクに決定的な役割を果たす可能性があります.
科学分野:
- 神経科学は神経科学である.
- バイオケミストリー バイオケミストリー
- 分子生物学は分子生物学である.
背景:
- ニューロンの酵素ウビキチンC末端ヒドロラーゼ-L1 (UCH-L1) は,パーキンソン病 (PD) と関連しています.
- 特定のUCH-L1変異はPDの感受性を高め,アルファ-シヌクレインの蓄積を引き起こし,その既知のヒドロラーゼ活性によって説明できない効果である.
研究 の 目的:
- UCH-L1.1.の二重酵素活性について調査する.
- UCH-L1の活動がパーキンソン病の病原化とニューロンの健康における役割を調査する.
主な方法:
- 酵素活性アッセイは,UCH-L1のヒドローラゼとリガゼ機能を特徴付けるためのものです.
- PDリスクに関連するS18Yポリモルフィズムを含むUCH-L1変異体の分析.
- アルファ-シヌクレインレベルに対するUCH-L1活性の影響を評価するための細胞研究.
主要な成果:
- UCH-L1は第2の,二分化に依存する,ユビキチルリガゼの活性を示している.
- PD-保護性S18Y変種は,野生型UCH-L1.1と比較して,リガース活性が低下しているが,正常なヒドロラース活性を示している.
- リガゼ活性に加えて,ヒドロラゼ活性も,UCH-L1の細胞効果に関与しています.
結論:
- UCH-L1は,ヒドロラーゼとユビキチルリガゼの両方の活性を有し,酵素の単一活性仮定に異議を唱える.
- UCH-L1の二重の酵素機能は,タンパク質分解とニューロンのホメオスタシスに潜在的に重要な役割を果たします.
- UCH-L1のリガース活性を理解することは,パーキンソン病のメカニズムと潜在的な治療目標に関する新しい洞察を提供します.
関連する概念動画
01:37Neural Regulation
34.8K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
34.8K
01:22Lysosomal Hydrolases
3.5K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.5K
02:41Lethal Alleles
11.3K
Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
11.3K
01:15Parkinson's Disease: Overview
2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
01:24Parkinson Disease l: Introduction
28
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of...
28
01:24Parkinson Disease ll: Pathophysiology
28
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
28